Clinical trial
The Study on the Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
NCT05099757 is registered in ClinicalTrials.gov with Shanxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study on the Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
- Lead sponsor
- Shanxi Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 20, 2022
- Completion date
- December 15, 2023
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b vaccine